Jazz Pharmaceuticals Presents Neurology Drug Data at AAN
DUBLIN, Ireland, April 9, 2026 Jazz Pharmaceuticals plc has announced the presentation of six scientific abstracts, including one oral...
drug development
Advertisement
Innovent Showcases Tri-Specific Autoimmune Therapy Data
SAN FRANCISCO & SUZHOU, China, April 9, 2026 Innovent Biologics, Inc. has unveiled preclinical data for its novel tri-specific...
DifGen, Apotex Win FDA Approval for Nintedanib Capsules
MIRAMAR, Fla., April 9, 2026 DifGen Pharmaceuticals LLC, in collaboration with Apotex Inc., has announced that the U.S. Food...
ArkBio Advances AK0406 Phase I Trial for Influenza
SHANGHAI, April 10, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. has announced a key clinical milestone with the successful dosing...
Fortrea Launches AI-Powered FIT Platform to Transform Clinical Trials
DURHAM, N.C., April 7, 2026 Fortrea has launched its advanced AI-powered platform, Fortrea Intelligent Technology™ (FIT), aimed at transforming...
Advertisements
Immutrin Raises $87M to Advance Amyloidosis Antibody Therapy
CAMBRIDGE, UK, April 8, 2026 Immutrin Ltd has successfully raised £65 million ($87 million) in an oversubscribed Series A...
Insmed CEDAR Study Misses Endpoints in HS Trial
BRIDGEWATER, N.J., April 7, 2026 Insmed Incorporated has announced that its Phase 2b CEDAR clinical trial evaluating brensocatib in...
ALS Research at Risk from Proposed FY27 Budget Cuts
ARLINGTON, Virginia, United States, April 7, 2026 The ALS Association has issued a strong statement warning that the proposed...
Kiora Raises $24M to Advance Retinal Therapies
ENCINITAS, California, United States, April 7, 2026 Kiora Pharmaceuticals, Inc. announced the successful completion of a private placement financing...
Sanofi Lunsekimig Shows Strong Phase 2 Results in Asthma
Paris, France, April 7, 2026 Phase 2 Success Across Respiratory Indications In a major advancement for respiratory disease therapeutics,...
Advertisement
